Viatris (VTRS) Short-Term Debt issuances (2020 - 2025)

Viatris' (VTRS) quarterly Short-Term Debt issuances came in at -$1.5 million in Q4 2025, little changed year-on-year from -$1.5 million in Q4 2024, and down 600.0% quarter-over-quarter from $300000.0 in Q3 2025.

Viatris (VTRS) Short-Term Debt issuances (2020 - 2025) Analysis & Trends

Viatris' Short-Term Debt issuances history runs 6 years deep, the most recent figure standing at -$1.5 million for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances changed 0.0% year-over-year to -$1.5 million in Q4 2025; TTM through Mar 2026 was -$1.2 million, a 185.71% decrease from a year earlier, with the FY2025 full-year figure at $200000.0, changed N/A from the prior year.
  • Short-Term Debt issuances fell to -$1.5 million in Q4 2025 per VTRS's latest filing, from $300000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $1.3 billion in Q2 2021 and bottomed at -$1.1 billion in Q1 2021.
  • The 5-year median for Short-Term Debt issuances is -$1.5 million (2024), against an average of -$64.7 million.
  • Across the five-year window, Short-Term Debt issuances jumped 124.42% in 2023 and plunged 1600.0% in 2024, its largest moves.
  • Year by year, Short-Term Debt issuances stood at -$214.0 million in 2021, then sank by 133.83% to -$500.4 million in 2022, then soared by 100.02% to $100000.0 in 2023, then plunged by 1600.0% to -$1.5 million in 2024, then changed by 0.0% to -$1.5 million in 2025.
  • Per Business Quant, the three latest VTRS Short-Term Debt issuances figures stand at -$1.5 million (Q4 2025), $300000.0 (Q3 2025), and $1.4 million (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.50 Mn
Dec 31, 2025 -1.50 Mn
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Mar 31, 2025 1.40 Mn
Mar 31, 2025 1.40 Mn
Dec 31, 2024 -1.50 Mn
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 1.50 Mn
Sep 30, 2024 1.50 Mn
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 -22.90 Mn
Sep 30, 2023 -22.90 Mn
Jun 30, 2023 -181.50 Mn
Jun 30, 2023 -181.50 Mn
Mar 31, 2023 204.60 Mn
Mar 31, 2023 204.60 Mn
Dec 31, 2022 -500.40 Mn
Dec 31, 2022 -500.40 Mn